APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Podophyllin

Podophyllin is a non-alkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species. Under the trade names Condylox, a gel, and Wartec, a solution or cream, it is used on the skin as a topical treatment of external genital warts, caused by some types of the human papillomavirus (HPV), and other warts. PPT and its synthetic derivatives display a wide selection in medical applications such as purgative, vesicant, antirheumatic, antiviral, and antitumor agents. These derivatives include etoposide and teniposide. Their anticancer activity has been heavily under study and used in various chemotherapies, including lung cancer, lymphomas, and genital tumors

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Podophyllin is a non-alkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species. Under the trade names Condylox, a gel, and Wartec, a solution or cream, it is used on the skin as a topical treatment of external genital warts, caused by some types of the human papillomavirus (HPV), and other warts. PPT and its synthetic derivatives display a wide selection in medical applications such as purgative, vesicant, antirheumatic, antiviral, and antitumor agents. These derivatives include etoposide and teniposide. Their anticancer activity has been heavily under study and used in various chemotherapies, including lung cancer, lymphomas, and genital tumors

Selected research

Market Outlook & Growth Opportunities

Global Podophyllin Market Outlook and Growth Opportunities 2026

Report ID 173332350423 December 2025195 pages

Choose your research edition.

Industry ResearchPodophyllin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Podophyllin Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Podophyllin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Podophyllin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Podophyllin Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Podophyllin is a non-alkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species. Under the trade names Condylox, a gel, and Wartec, a solution or cream, it is used on the skin as a topical treatment of external genital warts, caused by some types of the human papillomavirus (HPV), and other warts. PPT and its synthetic derivatives display a wide selection in medical applications such as purgative, vesicant, antirheumatic, antiviral, and antitumor agents. These derivatives include etoposide and teniposide. Their anticancer activity has been heavily under study and used in various chemotherapies, including lung cancer, lymphomas, and genital tumors

Global Podophyllin key players include MP Biomedicals, Haoxiang, Haoxuan, Perrigo, Himpharm, etc. Global top five manufacturers hold a share over 65%.

USA is the largest market, with a share over 40%, followed by China and India, both have a share over 25%.

Read the full market overview

In terms of product, 20%-50% of Podophyllin is the largest segment, with a share over 70%. And in terms of application, the largest application is Podophyllotoxin Tincture, followed by Podophyllotoxin Cream, etc.

This report provides an overview of the global Podophyllin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Podophyllin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Podophyllin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Podophyllin market size, projected growth trends, production technologies, key applications, and end-use industries.

Podophyllin Segment by Company

MP Biomedicals

Perrigo

Himpharm

Haoxiang

Haoxuan

Dajiang

Huahai

Huawei

Podophyllin Segment by Type

<20% of Podophyllin

20%-50% of Podophyllin

>50% of Podophyllin

Podophyllin Segment by Application

Podophyllotoxin Tincture

Podophyllotoxin Cream

Others

Podophyllin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Podophyllin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Podophyllin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Podophyllin significant trends, drivers, influence factors in global and regions.

6. To analyze Podophyllin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Podophyllin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Podophyllin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Podophyllin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Podophyllin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Podophyllin industry.

Chapter 3: Detailed analysis of Podophyllin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Podophyllin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Podophyllin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Podophyllin Industry Trends Table 2. Podophyllin Industry Drivers Table 3. Podophyllin Industry Opportunities and Challenges Table 4. Podophyllin Industry Restraints Table 5. Global Podophyllin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Podophyllin Revenue Share by Company (2021-2026) Table 7. Global Podophyllin Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Podophyllin Sales Volume Share by Company (2021-2026) Table 9. Global Podophyllin Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Podophyllin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Podophyllin Key Company Manufacturing Base & Headquarters Table 12. Global Podophyllin Company, Product Type & Application Table 13. Global Podophyllin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Podophyllin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of <20% of Podophyllin Table 18. Significant Companies of 20%-50% of Podophyllin Table 19. Significant Companies of >50% of Podophyllin Table 20. Global Podophyllin Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Podophyllin Sales Volume by Type (2021-2026) & (Kg) Table 22. Global Podophyllin Sales Volume by Type (2027-2032) & (Kg) Table 23. Global Podophyllin Sales Volume Share by Type (2021-2026) Table 24. Global Podophyllin Sales Volume Share by Type (2027-2032) Table 25. Global Podophyllin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Podophyllin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Podophyllin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Podophyllin Sales Value Share by Type (2021-2026) Table 29. Global Podophyllin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Podophyllotoxin Tincture Table 31. Significant Companies of Podophyllotoxin Cream Table 32. Significant Companies of Others Table 33. Global Podophyllin Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Podophyllin Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Podophyllin Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Podophyllin Sales Volume Share by Application (2021-2026) Table 37. Global Podophyllin Sales Volume Share by Application (2027-2032) Table 38. Global Podophyllin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Podophyllin Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Podophyllin Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Podophyllin Sales Value Share by Application (2021-2026) Table 42. Global Podophyllin Sales Value Share by Application (2027-2032) Table 43. Global Podophyllin Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Podophyllin Sales by Region (2021-2026) & (Kg) Table 45. Global Podophyllin Sales Market Share by Region (2021-2026) Table 46. Global Podophyllin Sales by Region (2027-2032) & (Kg) Table 47. Global Podophyllin Sales Market Share by Region (2027-2032) Table 48. Global Podophyllin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Podophyllin Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Podophyllin Sales Value Share by Region (2021-2026) Table 51. Global Podophyllin Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Podophyllin Sales Value Share by Region (2027-2032) Table 53. Global Podophyllin Market Average Price (USD/Kg) by Region (2021-2026) Table 54. Global Podophyllin Market Average Price (USD/Kg) by Region (2027-2032) Table 55. Global Podophyllin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Podophyllin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Podophyllin Sales by Country (2021-2026) & (Kg) Table 58. Global Podophyllin Sales Market Share by Country (2021-2026) Table 59. Global Podophyllin Sales by Country (2027-2032) & (Kg) Table 60. Global Podophyllin Sales Market Share by Country (2027-2032) Table 61. Global Podophyllin Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Podophyllin Sales Value Market Share by Country (2021-2026) Table 63. Global Podophyllin Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Podophyllin Sales Value Market Share by Country (2027-2032) Table 65. MP Biomedicals Company Information Table 66. MP Biomedicals Business Overview Table 67. MP Biomedicals Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 68. MP Biomedicals Podophyllin Product Portfolio Table 69. MP Biomedicals Recent Development Table 70. Perrigo Company Information Table 71. Perrigo Business Overview Table 72. Perrigo Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 73. Perrigo Podophyllin Product Portfolio Table 74. Perrigo Recent Development Table 75. Himpharm Company Information Table 76. Himpharm Business Overview Table 77. Himpharm Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 78. Himpharm Podophyllin Product Portfolio Table 79. Himpharm Recent Development Table 80. Haoxiang Company Information Table 81. Haoxiang Business Overview Table 82. Haoxiang Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 83. Haoxiang Podophyllin Product Portfolio Table 84. Haoxiang Recent Development Table 85. Haoxuan Company Information Table 86. Haoxuan Business Overview Table 87. Haoxuan Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 88. Haoxuan Podophyllin Product Portfolio Table 89. Haoxuan Recent Development Table 90. Dajiang Company Information Table 91. Dajiang Business Overview Table 92. Dajiang Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 93. Dajiang Podophyllin Product Portfolio Table 94. Dajiang Recent Development Table 95. Huahai Company Information Table 96. Huahai Business Overview Table 97. Huahai Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 98. Huahai Podophyllin Product Portfolio Table 99. Huahai Recent Development Table 100. Huawei Company Information Table 101. Huawei Business Overview Table 102. Huawei Podophyllin Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 103. Huawei Podophyllin Product Portfolio Table 104. Huawei Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Podophyllin Distributors List Table 108. Podophyllin Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Podophyllin Product Image Figure 2. Global Podophyllin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Podophyllin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Podophyllin Sales (2021-2032) & (Kg) Figure 5. Global Podophyllin Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Podophyllin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. <20% of Podophyllin Image Figure 10. 20%-50% of Podophyllin Image Figure 11. >50% of Podophyllin Image Figure 12. Global Podophyllin Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Podophyllin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Podophyllin Sales Volume Share by Type (2021-2032) Figure 15. Global Podophyllin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Podophyllin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Podophyllin Sales Value Share by Type (2021-2032) Figure 18. Podophyllotoxin Tincture Image Figure 19. Podophyllotoxin Cream Image Figure 20. Others Image Figure 21. Global Podophyllin Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Podophyllin Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Podophyllin Sales Volume Share by Application (2021-2032) Figure 24. Global Podophyllin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Podophyllin Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Podophyllin Sales Value Share by Application (2021-2032) Figure 27. Global Podophyllin Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Podophyllin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Podophyllin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Podophyllin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Podophyllin Sales Value (2021-2032) & (US$ Million) Figure 32. North America Podophyllin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Podophyllin Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Podophyllin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Podophyllin Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Podophyllin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Podophyllin Sales Value (2021-2032) & (US$ Million) Figure 38. South America Podophyllin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Podophyllin Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Podophyllin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Podophyllin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Podophyllin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Podophyllin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Podophyllin Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Podophyllin Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • <20% of Podophyllin
  • 20%-50% of Podophyllin
  • >50% of Podophyllin
Applications
  • Podophyllotoxin Tincture
  • Podophyllotoxin Cream
  • Others
Companies covered
  • MP Biomedicals
  • Perrigo
  • Himpharm
  • Haoxiang
  • Haoxuan
  • Dajiang
  • Huahai
  • Huawei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Podophyllin Sales Value (2021-2032)
  4. 1.2.2 Global Podophyllin Sales Volume (2021-2032)
  5. 1.2.3 Global Podophyllin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Podophyllin Market Dynamics
  1. 2.1 Podophyllin Industry Trends
  2. 2.2 Podophyllin Industry Drivers
  3. 2.3 Podophyllin Industry Opportunities and Challenges
  4. 2.4 Podophyllin Industry Restraints
3 Podophyllin Market by Company
  1. 3.1 Global Podophyllin Company Revenue Ranking in 2025
  2. 3.2 Global Podophyllin Revenue by Company (2021-2026)
  3. 3.3 Global Podophyllin Sales Volume by Company (2021-2026)
  4. 3.4 Global Podophyllin Average Price by Company (2021-2026)
  5. 3.5 Global Podophyllin Company Ranking (2024-2026)
  6. 3.6 Global Podophyllin Company Manufacturing Base and Headquarters
  7. 3.7 Global Podophyllin Company Product Type and Application
  8. 3.8 Global Podophyllin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Podophyllin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Podophyllin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Podophyllin Market by Type
  1. 4.1 Podophyllin Type Introduction
  2. 4.1.1 <20% of Podophyllin
  3. 4.1.2 20%-50% of Podophyllin
  4. 4.1.3 >50% of Podophyllin
  5. 4.2 Global Podophyllin Sales Volume by Type
  6. 4.2.1 Global Podophyllin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Podophyllin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Podophyllin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Podophyllin Sales Value by Type
  10. 4.3.1 Global Podophyllin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Podophyllin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Podophyllin Sales Value Share by Type (2021-2032)
5 Podophyllin Market by Application
  1. 5.1 Podophyllin Application Introduction
  2. 5.1.1 Podophyllotoxin Tincture
  3. 5.1.2 Podophyllotoxin Cream
  4. 5.1.3 Others
  5. 5.2 Global Podophyllin Sales Volume by Application
  6. 5.2.1 Global Podophyllin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Podophyllin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Podophyllin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Podophyllin Sales Value by Application
  10. 5.3.1 Global Podophyllin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Podophyllin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Podophyllin Sales Value Share by Application (2021-2032)
6 Podophyllin Regional Sales and Value Analysis
  1. 6.1 Global Podophyllin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Podophyllin Sales by Region (2021-2032)
  3. 6.2.1 Global Podophyllin Sales by Region: 2021-2026
  4. 6.2.2 Global Podophyllin Sales by Region (2027-2032)
  5. 6.3 Global Podophyllin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Podophyllin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Podophyllin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Podophyllin Sales Value by Region (2027-2032)
  9. 6.5 Global Podophyllin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Podophyllin Sales Value (2021-2032)
  12. 6.6.2 North America Podophyllin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Podophyllin Sales Value (2021-2032)
  15. 6.7.2 Europe Podophyllin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Podophyllin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Podophyllin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Podophyllin Sales Value (2021-2032)
  21. 6.9.2 South America Podophyllin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Podophyllin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Podophyllin Sales Value Share by Country, 2025 VS 2032
7 Podophyllin Country-level Sales and Value Analysis
  1. 7.1 Global Podophyllin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Podophyllin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Podophyllin Sales by Country (2021-2032)
  4. 7.3.1 Global Podophyllin Sales by Country (2021-2026)
  5. 7.3.2 Global Podophyllin Sales by Country (2027-2032)
  6. 7.4 Global Podophyllin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Podophyllin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Podophyllin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Podophyllin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Podophyllin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Podophyllin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Podophyllin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Podophyllin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Podophyllin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Podophyllin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Podophyllin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Podophyllin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Podophyllin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Podophyllin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Podophyllin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Podophyllin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Podophyllin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Podophyllin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Podophyllin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Podophyllin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Podophyllin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Podophyllin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Podophyllin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Podophyllin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Podophyllin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Podophyllin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Podophyllin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Podophyllin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Podophyllin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Podophyllin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Podophyllin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Podophyllin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Podophyllin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Podophyllin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Podophyllin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Podophyllin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Podophyllin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Podophyllin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Podophyllin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Podophyllin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Podophyllin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Podophyllin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Podophyllin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Podophyllin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Podophyllin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Podophyllin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Podophyllin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Podophyllin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Podophyllin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Podophyllin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Podophyllin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Podophyllin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Podophyllin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Podophyllin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Podophyllin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Podophyllin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Podophyllin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Podophyllin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Podophyllin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Podophyllin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Podophyllin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Podophyllin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Podophyllin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Podophyllin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Podophyllin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Podophyllin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Podophyllin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Podophyllin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Podophyllin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Podophyllin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Podophyllin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Podophyllin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Podophyllin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Podophyllin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Podophyllin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Podophyllin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Podophyllin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Podophyllin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Podophyllin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Podophyllin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Podophyllin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Podophyllin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Podophyllin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Podophyllin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Podophyllin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Podophyllin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Podophyllin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MP Biomedicals
  2. 8.1.1 MP Biomedicals Company Information
  3. 8.1.2 MP Biomedicals Business Overview
  4. 8.1.3 MP Biomedicals Podophyllin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 MP Biomedicals Podophyllin Product Portfolio
  6. 8.1.5 MP Biomedicals Recent Developments
  7. 8.2 Perrigo
  8. 8.2.1 Perrigo Company Information
  9. 8.2.2 Perrigo Business Overview
  10. 8.2.3 Perrigo Podophyllin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Perrigo Podophyllin Product Portfolio
  12. 8.2.5 Perrigo Recent Developments
  13. 8.3 Himpharm
  14. 8.3.1 Himpharm Company Information
  15. 8.3.2 Himpharm Business Overview
  16. 8.3.3 Himpharm Podophyllin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Himpharm Podophyllin Product Portfolio
  18. 8.3.5 Himpharm Recent Developments
  19. 8.4 Haoxiang
  20. 8.4.1 Haoxiang Company Information
  21. 8.4.2 Haoxiang Business Overview
  22. 8.4.3 Haoxiang Podophyllin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Haoxiang Podophyllin Product Portfolio
  24. 8.4.5 Haoxiang Recent Developments
  25. 8.5 Haoxuan
  26. 8.5.1 Haoxuan Company Information
  27. 8.5.2 Haoxuan Business Overview
  28. 8.5.3 Haoxuan Podophyllin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Haoxuan Podophyllin Product Portfolio
  30. 8.5.5 Haoxuan Recent Developments
  31. 8.6 Dajiang
  32. 8.6.1 Dajiang Company Information
  33. 8.6.2 Dajiang Business Overview
  34. 8.6.3 Dajiang Podophyllin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Dajiang Podophyllin Product Portfolio
  36. 8.6.5 Dajiang Recent Developments
  37. 8.7 Huahai
  38. 8.7.1 Huahai Company Information
  39. 8.7.2 Huahai Business Overview
  40. 8.7.3 Huahai Podophyllin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Huahai Podophyllin Product Portfolio
  42. 8.7.5 Huahai Recent Developments
  43. 8.8 Huawei
  44. 8.8.1 Huawei Company Information
  45. 8.8.2 Huawei Business Overview
  46. 8.8.3 Huawei Podophyllin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Huawei Podophyllin Product Portfolio
  48. 8.8.5 Huawei Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Podophyllin Value Chain Analysis
  2. 9.1.1 Podophyllin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Podophyllin Sales Mode & Process
  6. 9.2 Podophyllin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Podophyllin Distributors
  9. 9.2.3 Podophyllin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst